Q2 2026 Holdings
Filed 2026-08-14 | 50 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $214.3M | 640,000 | 11.0% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $136.2M | 17,878,594 | 7.0% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $126.3M | 4,615,612 | 6.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $110.7M | 2,657,521 | 5.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $109.9M | 6,000,000 | 5.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $102.0M | 2,510,000 | 5.2% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $100.1M | 7,000,000 | 5.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $92.5M | 3,285,596 | 4.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $90.0M | 675,000 | 4.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $73.1M | 750,000 | 3.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $63.2M | 900,000 | 3.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $62.4M | 3,205,433 | 3.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $58.6M | 2,390,605 | 3.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $50.8M | 533,340 | 2.6% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $45.7M | 3,978,229 | 2.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $41.0M | 550,000 | 2.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $40.6M | 1,300,000 | 2.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $38.8M | 2,610,000 | 2.0% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $32.0M | 2,465,348 | 1.6% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $30.4M | 550,000 | 1.6% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $27.5M | 2,106,000 | 1.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $26.9M | 2,150,000 | 1.4% |
| Damora Therapeutics Inc(GLTO) | COM | 36322Q206 | $26.0M | 1,000,000 | 1.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $25.9M | 750,000 | 1.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $22.0M | 2,344,971 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $20.0M | 225,000 | 1.0% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $18.8M | 400,000 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $16.9M | 500,000 | 0.9% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $16.8M | 475,000 | 0.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.6M | 5,000,000 | 0.8% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $13.8M | 1,297,500 | 0.7% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $13.3M | 50,000 | 0.7% |
| Kailera Therapeutics Inc(KLRA) | COMMON STOCK | 482931102 | $12.1M | 550,000 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.0M | 75,000 | 0.4% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $7.7M | 1,028,242 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $7.6M | 150,000 | 0.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $6.3M | 100,000 | 0.3% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $6.2M | 3,570,000 | 0.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.7M | 125,000 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $4.6M | 175,000 | 0.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $4.1M | 50,000 | 0.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.0M | 75,000 | 0.2% |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | $4.0M | 370,000 | 0.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.9M | 100,000 | 0.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $3.8M | 1,250,000 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.6M | 200,000 | 0.2% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $3.3M | 175,000 | 0.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.9M | 50,000 | 0.1% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $2.5M | 1,000,000 | 0.1% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A305 | $100.0K | 5,498 | 0.0% |